These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3606164)

  • 21. [Therapy of psoriasis].
    Christophers E
    Dtsch Med Wochenschr; 1983 Mar; 108(9):348-9. PubMed ID: 6825613
    [No Abstract]   [Full Text] [Related]  

  • 22. Retinoids and PUVA in psoriasis.
    Shuster S; Marks JM; Lawrence CM
    Br J Dermatol; 1985 Jan; 112(1):122-3. PubMed ID: 3970833
    [No Abstract]   [Full Text] [Related]  

  • 23. Retinoids and PUVA in psoriasis.
    Wolff K; Hönigsmann H
    Br J Dermatol; 1984 Aug; 111(2):247-8. PubMed ID: 6466564
    [No Abstract]   [Full Text] [Related]  

  • 24. Etretinate for psoriasis.
    Med Lett Drugs Ther; 1987 Jan; 29(731):9-10. PubMed ID: 3540554
    [No Abstract]   [Full Text] [Related]  

  • 25. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
    Mom A; Aresca S; Fuente G; Pecorini V; Pellerano G; Perez V
    Acta Derm Venereol; 1982; 62(4):357-8. PubMed ID: 6183878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of etretinate for the PUVA-dependent psoriatic.
    Logan RA
    Clin Exp Dermatol; 1987 Mar; 12(2):98-102. PubMed ID: 3677479
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of psoriasis by oral PUVA therapy combined with aromatic retinoid (Ro 10-9359; Tigason).
    Grupper C; Berretti B
    Dermatologica; 1981; 162(5):404-13. PubMed ID: 7250475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience with the treatment of psoriatic arthritis using tigazon].
    Shakhtmeĭster IIa; Pokryshkin VI; Pisarenko MF; Shakhtmeĭster SI
    Vestn Dermatol Venerol; 1986; (2):37-9. PubMed ID: 3705734
    [No Abstract]   [Full Text] [Related]  

  • 30. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS; Fitzgerald E; Ellis CN; Lowe N; Goldfarb MT; Baughman RD
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psoriasis vulgaris. 2. Problems of the psoriatic patient--therapeutic possibilities].
    Lubach D
    Krankenpfl J; 1983 Sep; 21(9):17-9. PubMed ID: 6556385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
    Bordier C; Flechet ML; Thomine E; Lauret P
    Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
    Larsen FG
    Acta Derm Venereol Suppl (Stockh); 1994; 190():1-33. PubMed ID: 7900497
    [No Abstract]   [Full Text] [Related]  

  • 35. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etretinate approved.
    FDA Drug Bull; 1986 Nov; 16(2):16-7. PubMed ID: 3817343
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M
    Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
    [No Abstract]   [Full Text] [Related]  

  • 38. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy for psoriasis with methotrexate and etretinate.
    Tuyp E; MacKie RM
    J Am Acad Dermatol; 1986 Jan; 14(1):70-3. PubMed ID: 3950115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.